DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

Express Scripts (NASDAQ: ESRX)



company name or ticker
Company Photos
(Click to zoom)

IHF, ESRX, WLP, AET: ETF Outflow Alert

2015 Express Scripts Medicare Prescription Drug Plans Earn CMS 4-Star Quality And Performance Rating

2015 Express Scripts Medicare Prescription Drug Plans Earn CMS 4-Star Quality And Performance Rating

Gilead Sciences, inc. Stock's Green Light Sparks Offensive

Gilead Sciences will need to convince healthcare payers to prescribe its new hepatitis C drug Harvoni.

Why The Diplomat Pharmacy IPO Could Rock The Industry

Sector Update: Health Care Stocks Give Back Earlier Advance; Diplomat Pharmacy Up Big Following Disc

Sector Update: Health Care Stocks Give Back Earlier Advance; Diplomat Pharmacy Up Big Following Discounted IPO

Sector Update: Health Care

Diplomat Turns Bunt Pricing Into Homerun for IPO Buyers

Repro-Med Systems' Focus On Home-Care Market Could Lead To Substantial Payoff Or Buyout

3 Stocks Dragging The Health Services Industry Downward

2 Mutual Funds Holding Hospital Stocks

See More Articles...